Search results
Author(s):
Amir S Jadidi
,
Thomas Arentz
Added:
3 years ago
Adecade after its first description as ‘the electrophysiological substrate’ of atrial fibrillation,1 mapping complex fractionated atrial electrogram (CFAE) as an ablation target for atrial fibrillation (AF) remains highly controversial. Early high-density mapping studies of induced AF in humans revealed distinct mechanisms that underlie electrogram fractionation: collision areas of distinct…
View more
Author(s):
Xianxian Jiang
Added:
3 years ago
Author(s):
Stephen P Page
,
Mehul Dhinoja
Added:
3 years ago
Over the last 30 years, the role of catheter ablation for treating a wide range of arrhythmias has increased dramatically. The electrophysiological substrates of the more straightforward arrhythmias (such as atrio-ventricular reciprocating tachycardia and atrio-ventricular nodal re-entry tachycardia) have now been well defined and excellent long-term success rates can be achieved at minimal risk…
View more
Dominick J Angiolillo
Research Area(s) / Expertise:
Job title: Professor & Chief
Author
Giuseppe Tarantini
Author
Author(s):
Ankur Kalra
,
Sukhjinder Nijjer
Added:
4 months ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their…
View more
László Göbölös
Job title: Clinical Associate Professor
Author
Author(s):
Roderick Tung
Added:
1 year ago
In this short interview, Dr Roderick Tung (University of Arizona College of Medicine, Phoenix, AZ, US.) joins us at HRS 2022 to outline the findings from a multicenter US cardioneural ablation registry in a study designed to provide data on the safety and feasibility of catheter-based cardioneural ablation.
Discussion Points:
1. Aim of this study
2. Patient population, study design and endpoints…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
What are the take-home messages from ESC 22 and what are the implications for practice?
In this short wrap-up video of ESC 22, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) review the most impactful hot line and late-breaking trials of ESC Congress 2022.
Trials covered in detail include:
On clinical judgement after PCI
00:35:27:REVIVED-BCIS2: Study of…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022.
Which trials should we look out for?
Trials covered in detail include:
TAILOR-PCI: Tailored Antiplatelet Therapy Following PCI
ASCEND: A Study of…
View more